The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.
May 1, 2016|
Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?